Burden of illness in patients with treatment refractory myasthenia gravis
- 23 March 2018
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 58 (1) , 99-105
Abstract
Introduction: This study assessed the clinical burden of refractory myasthenia gravis (MG), relative to nonrefractory MG. Methods: Rates of myasthenic crises, exacerbations, inpatient hospitalizations, and emergency room (ER) visits over a 1‐year period were measured for 403 refractory, 3,811 nonrefractory, and 403 non‐MG control patients from two administrative health plan databases. Results: Compared with nonrefractory patients, a significantly greater percentage of refractory patients had at least one myasthenic crisis (21.3% vs. 6.1%; P < 0.001) and at least one exacerbation (71.2% vs. 32.4%; P < 0.001) over a 1‐year period. Refractory patients were also significantly more likely to be hospitalized and/or have an ER visit than nonrefractory patients and non‐MG controls (P < 0.001 for all). Discussion: Refractory MG patients have significantly greater clinical burden and are more likely to utilize intensive healthcare resources than nonrefractory patients. Furthermore, refractory patients may be at greater risk of crises throughout the disease course than previous studies have suggested. Muscle Nerve 58: 99–105, 2018Keywords
Funding Information
- Alexion Pharmaceuticals
This publication has 18 references indexed in Scilit:
- Randomized Trial of Thymectomy in Myasthenia GravisNew England Journal of Medicine, 2016
- International consensus guidance for management of myasthenia gravisNeurology, 2016
- Treatment-Refractory Myasthenia GravisJournal of Clinical Neuromuscular Disease, 2014
- Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 CountriesAmerican Journal of Epidemiology, 2011
- Rituximab in the management of refractory myasthenia gravisMuscle & Nerve, 2009
- Rebooting the Immune System with High‐Dose Cyclophosphamide for Treatment of Refractory Myasthenia GravisAnnals of the New York Academy of Sciences, 2008
- Myasthenia Gravis CrisisSouthern Medical Journal, 2008
- Lifetime course of myasthenia gravisMuscle & Nerve, 2007
- Myasthenic crisis: Guidelines for prevention and treatmentJournal of the Neurological Sciences, 2007
- Clinical evaluation and management of myasthenia gravisMuscle & Nerve, 2004